Clinical studies have shown that the NLRP3 protein expression and proinflammatory cytokines of IL-1β were increased in the colon mucosa of most IBD patients [6], and the level of IL-1β in the colon mucosa was positively correlated with disease severity [7]. Here, NLRP3 is linked to inflammatory bowel disease.